A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 25 October 2017 |
| Author/s |
author: Eileen Hacker Ralph Weichselbaum |
| Publication date | October 25, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |